715703007: Product containing linagliptin and metformin in oral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing linagliptin\...

\Product containing linagliptin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)

\Product containing linagliptin and metformin\Product containing linagliptin and metformin in oral dose form (medicinal product form)

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing linagliptin\Product containing linagliptin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing linagliptin\Product containing linagliptin and metformin\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing metformin\Product containing linagliptin and metformin\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing metformin\Product containing metformin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing quinazoline\Product containing linagliptin\Product containing linagliptin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing quinazoline\Product containing linagliptin\Product containing linagliptin and metformin\Product containing linagliptin and metformin in oral dose form (medicinal product form)

\Product manufactured as oral dose form\Product containing linagliptin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)
\Product manufactured as oral dose form\Product containing metformin in oral dose form (medicinal product form)\Product containing linagliptin and metformin in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3710609011 Product containing linagliptin and metformin in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3710610018 Linagliptin- and metformin-containing product in oral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Is a	Product manufactured as oral dose form	false	Inferred relationship	Existential restriction modifier
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Is a	Product containing linagliptin and metformin	true	Inferred relationship	Existential restriction modifier
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Has active ingredient	Metformin	true	Inferred relationship	Existential restriction modifier	1
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Has active ingredient	Linagliptin	true	Inferred relationship	Existential restriction modifier	2
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Is a	Product containing metformin in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Is a	Product containing linagliptin in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only linagliptin and metformin in oral dose form (medicinal product form)	Is a	True	Product containing linagliptin and metformin in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3710609011	Product containing linagliptin and metformin in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3710610018	Linagliptin- and metformin-containing product in oral dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module